top of page

Neon Laboratories Ltd. v. Medical Technologies Ltd. & Ors.

  • 4 days ago
  • 2 min read

A significant trademark case establishing the importance of prior use and the distinction between registration and actual commercial use of a trademark.


Short Description About the Case


This case concerned the pharmaceutical marks “ROFOL” and “PROFOL.” Medical Technologies Ltd. claimed rights in the mark PROFOL, while Neon Laboratories Ltd. subsequently adopted and used ROFOL. The dispute required the Supreme Court to consider the effect of prior registration, subsequent use, and the principle that priority in actual use can be decisive in trademark disputes.


Facts


Medical Technologies Ltd. and another company were engaged in the manufacture and marketing of pharmaceutical products and claimed reputation and goodwill in the market.

They used the trademark “PROFOL” in relation to their pharmaceutical preparation.


Neon Laboratories Ltd. adopted and used the mark “ROFOL” for a pharmaceutical product.

The plaintiffs approached the Court seeking an injunction, alleging that ROFOL was deceptively similar to PROFOL and was likely to cause confusion.


The dispute ultimately reached the Supreme Court concerning the respective rights arising from registration and subsequent commercial use.


Findings


The Supreme Court examined the relationship between registration of a trademark and actual use of the mark in the market.


The Court emphasized that registration does not automatically override the rights of a prior user in every circumstance.


The judgment discussed the importance of the “first user” principle, particularly in the context of passing off and competing pharmaceutical marks.


The Court also considered the fact that pharmaceutical products require particular caution because confusion between medicinal products can have serious consequences.


Suggestion


This case is highly useful in matters involving trademark infringement, passing off, prior use, first user principle, trademark registration, pharmaceutical trademarks and interim injunctions.

It can be cited where one party relies primarily on an earlier registration while the opposing party claims prior commercial use of the mark.


For practical legal use, this case supports the principle that registration and actual use are distinct concepts, and priority of use can have significant importance in determining competing trademark rights.


Judgment


The Supreme Court examined the competing rights of the parties and the effect of prior use and registration.


The judgment is an important authority on the first-user principle and the relationship between trademark registration and actual market use, particularly in pharmaceutical trademark disputes.

bottom of page